Nasdaq

Nasdaq DW Global Momentum Q3 2020 commentary

SaxoSelect Commentary
Instruments traded
Stocks
Asset classesGlobal equities (including emerging markets, excluding US companies)
Investment styleSystematic investing based on stocks’ relative strength
Quarterly return3.96% (net of fees)
Annualised volatility (since inception)21.5%

Market overview

The global economies and global markets continued their recovery in the third quarter which was a strong quarter across the board. It has been a wild ride in stock markets this year with elevated volatility along with strong returns. The U.S. Dollar fell during the quarter, and that gave international equities a relative strength for the first time in a long while. Emerging markets (MSCI Emerging Markets TR) led the way higher finishing up 9.7%. Developed markets (MSCI EAFE TR) didn’t fare as well finishing up only 4.8%.  

The global economy has begun to rebound from dramatic losses brought on earlier in the year when strict stay-at-home orders in many parts of the world caused the economy to contract rapidly. A lot will depend on countries around the globe having the ability to keep opening economies back up while still maintaining acceptable virus infection levels. Any speculation on how this will go is very difficult because we have never seen anything like this in modern history. The Nasdaq Dorsey Wright portfolio management team (the “Team”) is anticipating added volatility as the situation plays out, and the Team may need to make portfolio changes if things reverse course.

There was talk near the end of the quarter that value-stocks (attractively priced stocks) may start to re-assert itself versus growth-stocks (stocks priced for substantial future growth). The Team thinks it is premature to make that call. Growth-stocks dramatically outperformed during the quarter, which is just an extension of a multi-year trend.  There have been small pullbacks along the way where value has outperformed growth.  In each of those cases, growth has resumed leadership and pushed to new highs.  Until the Team sees Growth unable to resume leadership and break critical support levels versus Value, the Team remains committed to the dominant Growth theme.  

Portfolio performance

Jul6.52%
Aug
-0.54%
Sep
-1.86%
Since inception (March 2006*)
239.6%

Performance is net of all fees
* Performance prior to Nov 2017 occurred before the partnership with Saxo Bank A/S

Top 10 portfolio holdings (as of 30/09/20)
44.9%of total portfolio

DescriptionSymbol  % Mkt val
MERCADOUBRE INC COM
 MEU 6.5
NICE LTD ADR SPONSORED
 NICE 6.26
ARGENX SE ADR SPONSORED
 ARGX 5.98
GOLD FIELDS LTD ADR SPONSOREDGFI 5.63
TAL EDUCATION GROUP ADR
 TAL 4.05
 ANGLOGOLD ASHANTI LTD ADR SPONSOREDAU 3.7
 ASML HOLDING NV ADR SPONSOREDASML 3.51
 ICON PLC COMICLR 3.16
 ZTO EXPRESS (CAYMAN) INC ADR SPONSORED ZTO 3.13
 SIBANYE STILLWATER LTD ADR SPONSORED SBSW 3.03

Best performing positions

  • Gold Fields Limited operates as a gold producer with reserves and resources in Chile, South Africa, Ghana, Australia, and Peru. It holds interests in nine operating mines with an annual gold-equivalent production of approximately 2.2 million ounces, as well as gold mineral reserves of approximately 51.3 million ounces and mineral resources of approximately 115.7 million ounces. The company also holds copper mineral reserves and mineral resources. Gold Fields Limited was founded in 1887 and is based in Sandton, South Africa.

  • NICE Ltd. provides enterprise software solutions worldwide. The company operates in two segments, Customer Engagement, and Financial Crime and Compliance. NICE Ltd. was founded in 1986 and is based in Ra'anana, Israel.

  • Argenx SE, a clinical-stage biotechnology company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases, hematology, and cancer. argenx SE was founded in 2008 and is based in Breda, the Netherlands.

  • Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. The company was founded in 1984 and is headquartered in Hyderabad, India.

  • Sibanye Stillwater Limited operates as a precious metals mining company in South Africa, the United States, Zimbabwe, Canada, and ArgentinaSibanye Gold Limited was incorporated in 2002 and is headquartered in Weltevreden Park, South Africa.

Worst performing positions

  • Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Galapagos NV was founded in 1999 and is headquartered in Mechelen, Belgium.

  • ZTO Express Inc. provides express delivery and other value-added logistics services in the People's Republic of China. The company offers delivery services for e-commerce and traditional merchants, and other express service users. As of December 31, 2019, it operated a fleet of approximately 6,450 self-owned trucks. The company was founded in 2002 and is headquartered in Shanghai, the People's Republic of China.
     
  • Vipshop Holdings Limited operates as an online discount retailer for various brands in the People's Republic of China. The company was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.

  • AngloGold Ashanti Limited operates as a gold mining company. It also produces gold, silver, uranium, and sulphuric acid; and dóre bars. The company operates 14 mines and three projects in nine countries in South Africa, Continental Africa, the Americas, and Australia. AngloGold Ashanti Limited was incorporated in 1944 and is headquartered in Johannesburg, South Africa.

  • CRH plc, through its subsidiaries, manufactures and distributes building materials. It serves governments, contractors, homebuilders, homeowners, and sub-contractors. The company operates primarily in the Republic of Ireland, the United Kingdom, the rest of Europe, the United States, and internationally. CRH plc was founded in 1936 and is headquartered in Dublin, Ireland.

Outlook 

It has been a challenging year dealing with the global pandemic, but investment returns have been solid – especially momentum. The spread of COVID has caused a great deal of uncertainly. The Team’s process is not designed to guess what is going to happen.  The Team will wait for any trends to develop and position the portfolios accordingly.  

As the Team looks forward to the rest of the year, the Team believes there will be many opportunities for the strategy to capitalize.  

Disclaimer

Saxo Markets provides personal portfolio management via its SaxoSelect service. Before entering any managed portfolio, we must first take into account your investment objectives, goals and financial situation. 

This material should be considered as a marketing communication under the Financial Conduct Authority’s rules. Saxo Capital Markets UK Limited (SCML) undertakes reasonable efforts to ensure that any information published in this communication is reliable. SCML makes no representation or warranty, and assumes no liability, for the accuracy or completeness of any information contained in this communication. 

Investing in financial products always involves risk. As a general rule, you should only invest in financial products if you understand the risks associated with them. Investing in a portfolio with currency that differs from the base currency of your account carries the risk of exposure to changes in the rate of exchange between them. See the full Managed Portfolio Disclaimer for more information. Past performance is not a guide to future performance.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992